Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Lung Regional Ventilation Defect Severity Measured by Fluorine-19 Gas MRI

NCT01640288 is registered in ClinicalTrials.gov with Hal C Charles as lead sponsor.

NCT NCT01640288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01640288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Lung Regional Ventilation Defect Severity Measured by Fluorine-19 Gas MRI
Lead sponsor
Hal C Charles
Phase
Phase 1/2
Overall status
Completed
Start date
January 31, 2013
Completion date
August 10, 2018
Enrollment
171 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd